Asia Pacific Medical Foods Market Size & Outlook
Asia Pacific medical foods market, 2018-2030 (US$M)
Related Markets
Asia Pacific medical foods market highlights
- The Asia Pacific medical foods market generated a revenue of USD 6,483.2 million in 2023.
- The market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, oral was the largest revenue generating route of administration in 2023.
- Enteral is the most lucrative route of administration segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 6,483.2 million |
| Market revenue in 2030 | USD 9,937.0 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Oral |
| Fastest growing segment | Enteral |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral, Enteral |
| Key market players worldwide | Danone SA, Nestle SA, Fresenius SE & Co KGaA, Abbott Laboratories, Targeted Medical Pharma Inc, Mead Johnson Nutrition, Primus Pharmaceuticals |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 27.5% of the global medical foods market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,937.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Foods Market Scope
Medical Foods Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific medical foods market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical foods market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 69.17% in 2024. Horizon Databook has segmented the Asia Pacific medical foods market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of key players such as Abbott, Nestle, Danone, & Fresenius Kabi and high revenue generated by these companies in the Asia Pacific region is one of the key factors for the significant market share. Countries such as Japan, China, India, and Australia are some of the major countries in Asia Pacific.
The region has a large patient pool along with an increasing geriatric population. Lifestyle changes are leading to an increase in prevalence of various diseases such as cancer, diabetes, gastrointestinal disorders, and autoimmune diseases. This is ultimately expected to further increase the demand for medical foods for dietary management of chronic diseases.
Japan has a large elderly population, which has high predisposition to chronic conditions. Nutritional deficiencies are more common in aging population, and it is expected to boost the demand for medical foods in Asia Pacific.
Reasons to subscribe to Asia Pacific medical foods market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific medical foods market databook
-
Our clientele includes a mix of medical foods market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific medical foods market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific medical foods market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific medical foods market size, by country, 2018-2030 (US$M)
Asia Pacific Medical Foods Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
